| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $906.6M | +39.5% |
| Cost of Revenue | $590.8M | +37.6% |
| Gross Profit | $315.7M | +43.4% |
| R&D Expense | $15.4M | +23.7% |
| SG&A Expense | $102.1M | +34.3% |
| Operating Income | $73.8M | +74.6% |
| Interest Expense | $20.1M | +66.6% |
| Pre-tax Income | $38.4M | +281.6% |
| Income Tax | $8.8M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.4M | -42.9% |
| Accounts Receivable | $147.5M | +39.9% |
| Inventory | $172.1M | +54.4% |
| Current Assets | $466.6M | +5.6% |
| Total Assets | $1.69B | +46.5% |
| Current Liabilities | $249.6M | +35.8% |
| Long-term Debt | $497.1M | +99.7% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.9M | -50.6% |
| Investing Cash Flow | -$554.3M | -9891.2% |
| Financing Cash Flow | $420.7M | +4229.0% |
| +805.8% |
| Net Income | $29.7M | +225.7% |
| EPS (Basic) | $1.06 | +178.9% |
| EPS (Diluted) | $1.04 | +173.7% |
| Total Liabilities |
| $912.9M |
| +47.2% |
| Stockholders' Equity | $772.8M | +45.8% |